Cambrex Corporation

East Rutherford, NJ
Small Molecule API HPAPI Controlled Substances Oral Solid Dose Solid State Research Particle Engineering Drug Product (OSD) Controlled Release
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (9) ○ EMA GMP ○ MHRA GMP

Quick Facts: Cambrex Corporation

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
East Rutherford, NJ
Modalities
Small Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Cambrex Corporation

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (8 modalities)

Recent News 9 articles

news Wed, 30 Ap
Small Molecule CDMO Market Size | CAGR Of 7.2% - Market.us
Source →
news Wed, 26 Ma
Pharmaceutical CDMO for Formulations Market Size to Hit USD 103.33 Billion by 2035 - Precedence Research
Source →
news Tue, 24 Ma
Cambrex Advances US and European Expansions - CHEManager
Source →
news Tue, 08 Ju
U.S. Pharmaceutical CDMO Market Size to Hit USD 83.86 Billion by 2034 - BioSpace
Source →
news Tue, 08 Au
Avista Pharma Solutions Completes Expansion Of Analytical Laboratories At Durham Headquarters - Pharmaceutical Online
Source →
news Thu, 03 Ap
Small Molecule Innovator CDMO Market Size, Scope and Growth Analysis - Insightace Analytic
Source →
news Thu, 01 Ju
Active Pharmaceutical Ingredient CDMO Market Report, 2026-2033 - Grand View Research
Source →
news Mon, 23 Ju
EX-99.1 - SEC.gov
Source →
news Mon, 01 De
Pharmaceutical CDMO Market Size Worth USD 368.70 Bn By 2034 Driven by Biologics and Advanced Therapies Demand - BioSpace
Source →

Frequently Asked Questions About Cambrex Corporation

What is Cambrex Corporation's CDMO Signal Score?
Cambrex Corporation has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cambrex Corporation for a manufacturing program?
Use the free AI matchmaker to compare Cambrex Corporation against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
HPAPI CDMOs →

Similar CDMOs

Bend Bioscience
Bend, OR
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines
Codis
St. Louis, MO (US); Haverhill, UK (EU)
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying
Veranova
Devens, MA (US HQ); multiple global sites
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide